Navigation Links
Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis
Date:5/18/2010

HALMSTAD, Sweden, May 18, 2010 /PRNewswire/ --

- With Photo

The Redsense safety device is now cleared by FDA for Home/Self use and is consequently available to all patients with home hemodialysis in the US. Redsense safety device is designed to detect venous needle dislodgement during hemodialysis and its use has already improved in-clinic patient safety. Optimizing safety conditions for home hemodialysis users is a core ambition for Redsense Medical.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100518/391613 )

Dialysis equipment today is required to have a system which protects the patient from blood loss due to dislodgement of the venous needle. The commonly accepted solution is to monitor by the venous pressure alarm but a better solution has long been requested. Even with the routine supervision of medical staff still the venous needle can become dislodged: the dialysis machine will then continue to draw blood from the patient's artery however not returning blood in the loop circuit as the venous needle has become dislodged and the patient's blood ends up elsewhere. If undetected, this blood loss can have very serious consequences in only a few minutes. Redsense safety device provides a solution to this problem and detects venous needle dislodgement instantaneously; it only takes a few millilitres of blood on the sensor patch to sound the alarm.

It is well known that home hemodialysis allows for daily treatments, improving quality of life, morbidity and life expectancy. Home hemodialysis is also more cost-effective as it can free hospital beds and reduces the transport costs related to centralized dialysis care.

Being able to address the market for home hemodialysis is an important step according to, CEO Patrik Byhmer:

    - This is where Redsense really can make a difference. It's very
      satisfying being able to increase the level of safety among the users
      of home hemodialysis.

The company

Redsense Medical has offices in Sweden and in the U.S. (Chicago, IL). For more information: http://www.redsensemedical.com.

The product

The Redsense safety device is the results of close co-operation between medical staff and engineers. Redsense consists of two parts: a sensor patch and an alarm unit. An infrared signal is transmitted from the alarm unit to the sensor patch using fibre optic cable. In the event of bleeding, inner layers of the patch smear blood over the optical sensor, which triggers the alarm.


'/>"/>
SOURCE Redsense Medical AB
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ultra-Fine Metal Tubing Smoothes the Way for Miniaturized Medical Devices
2. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
3. TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes
4. China Sky One Medical Provides Sales Forecast for 13 New Products
5. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
6. Winner Medical Reports Second Quarter Results for the Fiscal Year 2010
7. China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call
8. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
9. PolyTouch Medical Ltd. Announces the Submission of a Premarket Application for PatchAssist - an Innovative Mesh Deployment and Placement Device for Laparoscopic Hernia Repair
10. BioMS Medical updates University of Alberta equity position
11. InterTech Service to Counter Widely Reported Problems in Automotive, Medical Device and Other Industries Requiring Rigorous Quality Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... -- Four US Biotech equities have been ... are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Arrowhead Pharmaceuticals Inc. ... and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ). ... are growing more bullish on the sector as a ... cash held overseas for tax reason by large US ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... SAN FRANCISCO, CA (PRWEB) , ... February 24, 2017 , ... ... awarding of a $224K grant from the National Institute of Mental Health (NIMH) for ... is based on Delpor’s PROZOR technology and is expected to deliver therapeutic ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:2/1/2017)... 1, 2017 IDTechEx Research, a leading provider ... announces the availability of a new report, Sensors for Robotics: ... Continue Reading ... ... robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts ...
Breaking Biology News(10 mins):